Public Health Strategies to Address Alzheimer's Disease and Related Dementias: The National Healthy Brain Initiative, BOLD Public Health Centers of Excellence, and Public Health Adoption Accelerator
ID: 355880Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCCDPHP (HHS-CDC-NCCDPHP)

Award Range

$750K - $3M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355880
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Public Health Strategies to Address Alzheimer's Disease and Related Dementias," aimed at enhancing public health initiatives through cooperative agreements. This initiative seeks to support organizations in developing and implementing strategies that align with the National Healthy Brain Initiative Road Map Series, focusing on areas such as dementia risk reduction, early detection, management, and caregiver support. The funding opportunity is critical as it addresses the rising prevalence of Alzheimer's disease, which significantly impacts public health, particularly among the aging U.S. population. Interested applicants can apply for one or more of the three components, with funding amounts ranging from $750,000 to $3 million, and must submit their applications by March 7, 2025, to be considered for awards expected to be announced by July 15, 2025. For further inquiries, applicants can contact Alisha Etheredge at BOLD@cdc.gov or call 770-488-7884.

    Point(s) of Contact
    Alisha Etheredge
    (770) 488-7884
    BOLD@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Demonstrations Reducing Dementia Disparities
    Active
    Office of the Assistant Secretary for Health
    The Office of the Assistant Secretary for Health is forecasting a federal grant opportunity titled "Demonstrations Reducing Dementia Disparities" aimed at funding innovative projects that address health disparities related to brain health in aging populations. The initiative seeks to support evidence-based and community-focused approaches that tackle social determinants of health and improve outcomes for groups disproportionately affected by dementia and related chronic illnesses. With an estimated total program funding of $5 million, the agency plans to award approximately nine grants, each ranging from $500,000 to $600,000, with applications due by February 13, 2025. Interested applicants can reach out to Alana Sutherland at OMHGrants@hhs.gov or by phone at 301-945-3668 for further information.
    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled "Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)." This initiative aims to support investigator-initiated research focused on identifying and evaluating potential risk factors associated with ALS, particularly those related to military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents. The program is significant for advancing understanding of ALS and its risk factors, especially in diverse populations, including racial and ethnic minorities and military veterans. Interested applicants can apply for funding ranging from $0 to $500,000, with an estimated total program funding of $7.5 million available for approximately eight awards. Applications must be submitted electronically by November 4, 2024, and inquiries can be directed to Candis M. Hunter, PhD, MSPH, REHS, at ncipcerpo@cdc.gov.
    Alzheimer's Disease Programs Initiative (ADPI) - Developing Dementia-Capable Community Health Worker Programs in the National Aging Network
    Active
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled "Alzheimer's Disease Programs Initiative (ADPI) - Developing Dementia-Capable Community Health Worker Programs in the National Aging Network." This initiative aims to establish twelve three-year cooperative agreements with Home and Community-Based Service organizations to enhance the dementia capabilities of Community Health Worker (CHW) programs, thereby equipping CHWs to better support individuals living with dementia and their caregivers through specialized training and culturally competent resources. The program is crucial for increasing access to meaningful support for family caregivers, aligning with recommendations from the RAISE Act Family Caregiving Advisory Council. Interested applicants, specifically private institutions of higher education, should note that the award ceiling is set at $250,000, with a total estimated program funding of $6 million, and the application period is expected to open in March 2025, with awards anticipated by August 2025. For further inquiries, contact Stephanie Bostic at stephanie.bostic@acl.hhs.gov or call 202-795-7345.
    Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Creutzfeldt-Jakob Disease (CJD) Increasing Educational Support for CJD Families and the Nation," aimed at enhancing educational resources for families affected by CJD and related prion diseases. The cooperative agreement seeks to provide timely information to families, public health service providers, and health professionals to improve monitoring and understanding of prion diseases, particularly in light of the ongoing chronic wasting disease (CWD) outbreak among deer and elk. Eligible applicants include states, political subdivisions, and nonprofit entities, with funding ranging from $75,000 to a maximum of $100,000, and an estimated total program funding of $500,000. Interested parties should note that applications must be submitted electronically by March 18, 2025, with awards expected to be announced by September 1, 2025; for further inquiries, contact Tracey Ponder at TPonder@cdc.gov or by phone at 404-639-0953.
    Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to address significant gaps in lupus awareness and care by supporting national organizations in reducing the time to diagnosis, improving care coordination, and enhancing self-management among lupus patients. The program is particularly focused on increasing healthcare provider education and promoting effective self-management tools for individuals affected by lupus, a systemic autoimmune disease that disproportionately impacts women, especially those from minority communities. The estimated total program funding is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are due by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.
    Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for early and late-stage clinical trials focused on Alzheimer's Disease (AD) and related dementias, as well as age-related cognitive decline. This initiative aims to develop and implement both pharmacological and non-pharmacological interventions to address cognitive and neuropsychiatric changes associated with these conditions, while also encouraging innovative trial designs and methodologies. Given the significant public health crisis posed by AD, which currently affects over six million Americans, this funding opportunity is part of a broader strategy to enhance research and develop effective therapies across the disease spectrum. Applications are due by January 7, 2025, and interested parties can find more information and submit proposals through the NIH ASSIST online system or contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing Public Health Actions to Prevent and Control Chronic Disease in the U.S. Territories and Freely Associated States
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Advancing Public Health Actions to Prevent and Control Chronic Disease in the U.S. Territories and Freely Associated States." This cooperative agreement aims to support integrated, evidence-based strategies to prevent and manage chronic diseases in U.S. territories and freely associated states, addressing significant health challenges such as high disease burden and limited healthcare infrastructure. The program will focus on reducing modifiable risk factors associated with chronic diseases, with an estimated total funding of $17,450,000 available for approximately eight awards, ranging from $230,000 to a ceiling of $1,400,000. Interested applicants must submit their proposals by January 15, 2025, and can contact Monique Young at 770-488-3434 or via email at islandprogdp25-0024@cdc.gov for further information.
    Evaluate STEADI-based Fall Prevention in Assisted Living Facilities
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting proposals for a cooperative agreement aimed at evaluating STEADI-based fall prevention strategies in assisted living facilities. The objective is to conduct a well-designed study within two or more facilities that serve diverse populations, particularly focusing on groups with high rates of falls and fall-related injuries, such as Tribal and rural populations, economically disadvantaged individuals, and those with cognitive or physical limitations. This initiative is crucial for enhancing the safety and well-being of older adults (aged 65 and above) in assisted living settings. The total estimated funding for this program is $2.8 million, with a maximum award ceiling of $700,000, and applications must be submitted electronically by December 2, 2024, to be considered. For further inquiries, interested applicants can contact Joyce Dieterly at ncipcerpo@cdc.gov.
    Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)" through a cooperative agreement. This initiative aims to evaluate the effectiveness of existing Clinical Community Linkage (CCL) and social connectedness programs in reducing disparities related to diabetes risk factors, incidence, and complications, while also assessing the impact of various mechanisms on diabetes outcomes. The program is critical for informing future scaling of effective interventions and understanding the characteristics of successful programs, particularly for populations facing documented disparities. The estimated total program funding is $3,150,000, with an award ceiling of $350,000 and an expected three awards. Interested applicants must submit their proposals electronically by January 6, 2025, and can direct inquiries to Dr. Celeste Sanders at CSanders4@cdc.gov or by phone at 770-488-2536.
    Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at increasing awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. The initiative seeks to enhance AGS surveillance, patient care, and public understanding through strategies that include public health tracking, targeted education for at-risk populations, and dissemination of knowledge among stakeholders. With an estimated total program funding of $2,250,000, the CDC anticipates awarding three grants, with individual awards ranging from $25,000 to $1,000,000. Interested applicants can reach out to Jeff Borchert at JBorchert@cdc.gov or by phone at 970-221-6494, with applications due by January 22, 2025, and awards expected to be announced by July 1, 2025.